Literature DB >> 11705957

Chlamydia pneumoniae infects and multiplies in lymphocytes in vitro.

S Haranaga1, H Yamaguchi, H Friedman, S Izumi, Y Yamamoto.   

Abstract

The obligate intracellular pathogen Chlamydia (Chlamydophila) pneumoniae is known to be associated with some chronic inflammatory diseases, such as atherosclerosis. Interaction between C. pneumoniae and immune cells is important in the development of such diseases. However, susceptibility of immune cells, particularly lymphocytes, to C. pneumoniae infection has not been reported, even though lymphocytes play a pivotal role in the development of the diseases caused by this bacterium. In this regard, we examined the susceptibility of lymphocytes to C. pneumoniae infection in vitro. The results demonstrated that human peripheral blood lymphocytes as well as mouse spleen lymphocytes could be infected with C. pneumoniae. Furthermore, purified T lymphocytes as well as established T-lymphocyte cell line cells showed an obvious susceptibility to C. pneumoniae infection, indicating that T cells could be one of the host cells for this bacterial infection. These findings reveal a new infection site for C. pneumoniae, i.e., lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705957      PMCID: PMC98871          DOI: 10.1128/IAI.69.12.7753-7759.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells.

Authors:  K Wolf; E Fischer; T Hackstadt
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Chlamydia pneumoniae infection and asthma.

Authors:  D L Hahn
Journal:  Lancet       Date:  1992-05-09       Impact factor: 79.321

3.  Immunohistochemical characterization of inflammatory cells associated with advanced atherosclerosis.

Authors:  A L Ramshaw; D V Parums
Journal:  Histopathology       Date:  1990-12       Impact factor: 5.087

4.  Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10.

Authors:  Y Geng; R B Shane; K Berencsi; E Gonczol; M H Zaki; D J Margolis; G Trinchieri; A H Rook
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

5.  Detection of activated T lymphocytes in the human atherosclerotic plaque.

Authors:  G K Hansson; J Holm; L Jonasson
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

Review 6.  A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.

Authors:  J T Grayston; L A Campbell; C C Kuo; C H Mordhorst; P Saikku; D H Thom; S P Wang
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

7.  An immunohistochemical analysis of human aortic fatty streaks.

Authors:  J M Munro; J D van der Walt; C S Munro; J A Chalmers; E L Cox
Journal:  Hum Pathol       Date:  1987-04       Impact factor: 3.466

8.  T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1.

Authors:  S Stemme; J Holm; G K Hansson
Journal:  Arterioscler Thromb       Date:  1992-02

9.  Interferon-gamma induced resistance to Legionella pneumophila in susceptible A/J mouse macrophages.

Authors:  T W Klein; Y Yamamoto; H K Brown; H Friedman
Journal:  J Leukoc Biol       Date:  1991-01       Impact factor: 4.962

10.  T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis.

Authors:  E E Emeson; A L Robertson
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

View more
  9 in total

1.  Chlamydia pneumoniae resists antibiotics in lymphocytes.

Authors:  Hiroyuki Yamaguchi; Herman Friedman; Mayumi Yamamoto; Keigo Yasuda; Yoshimasa Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

2.  Depletion of resident Chlamydia pneumoniae through leukoreduction by filtration of blood for transfusion.

Authors:  Hideaki Ikejima; Herman Friedman; German F Leparc; Yoshimasa Yamamoto
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  Cytokine response of lymphocytes persistently infected with Chlamydia pneumoniae.

Authors:  Riho Takano; Hiroyuki Yamaguchi; Shigehiro Sugimoto; Shinichi Nakamura; Herman Friedman; Yoshimasa Yamamoto
Journal:  Curr Microbiol       Date:  2005-03-15       Impact factor: 2.188

4.  Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and -independent signaling and is reciprocally modulated by liver X receptor activation.

Authors:  Shuang Chen; Rosalinda Sorrentino; Kenichi Shimada; Yonca Bulut; Terence M Doherty; Timothy R Crother; Moshe Arditi
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

5.  Chlamydia pneumoniae growth inhibition in cells by the steroid receptor antagonist RU486 (mifepristone).

Authors:  Hiroyuki Yamaguchi; Shigeru Kamiya; Tomonori Uruma; Takako Osaki; Haruhiko Taguchi; Tomoko Hanawa; Minoru Fukuda; Hayato Kawakami; Hajime Goto; Herman Friedman; Yoshimasa Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

6.  Involvement of nicotinic acetylcholine receptors in controlling Chlamydia pneumoniae growth in epithelial HEp-2 cells.

Authors:  Hiroyuki Yamaguchi; Herman Friedman; Yoshimasa Yamamoto
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

7.  Novel Parachlamydia acanthamoebae quantification method based on coculture with amoebae.

Authors:  Junji Matsuo; Yasuhiro Hayashi; Shinji Nakamura; Marie Sato; Yoshihiko Mizutani; Masahiro Asaka; Hiroyuki Yamaguchi
Journal:  Appl Environ Microbiol       Date:  2008-08-29       Impact factor: 4.792

8.  Chlamydia pneumoniae infection of monocytes in vitro stimulates innate and adaptive immune responses relevant to those in Alzheimer's disease.

Authors:  Charles Lim; Christine J Hammond; Susan T Hingley; Brian J Balin
Journal:  J Neuroinflammation       Date:  2014-12-24       Impact factor: 8.322

9.  Detection of Chlamydia in the peripheral blood cells of normal donors using in vitro culture, immunofluorescence microscopy and flow cytometry techniques.

Authors:  Frances Cirino; Wilmore C Webley; Corrie West; Nancy L Croteau; Chester Andrzejewski; Elizabeth S Stuart
Journal:  BMC Infect Dis       Date:  2006-02-10       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.